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a b s t r a c t
Bovine rhinitis B virus (BRBV) shares many motifs and sequence similarities with foot-and-mouth disease
virus (FMDV). This study examined if the BRBV leader proteinase (Lpro ) could functionally replace that of
FMDV. A mutant A24LBRV3DYR FMDV engineered with the BRBV Lpro and an antigenic marker in the 3D
polymerase exhibited growth properties and eIF4G cleavage similar to parental A24WT virus. The
A24LBRV3DYR type I interferon activity in infected bovine cells resembled that of A24LL virus that lacks Lpro,
but this effect was less pronounced for A24LBRV3DYR infected porcine cells. In vivo studies showed that the
A24LBRV3DYR virus was attenuated in cattle, and exhibited low virulence in pigs exposed by direct contact.
The mutant virus induced protective immunity in cattle against challenge with parental A24WT. These
results provide evidence that Lpro of different Aphthoviruses are not fully functionally interchangeable and
have roles that may depend on the nature of the infected host.
Published by Elsevier Inc.
Introduction
Foot-and-Mouth Disease Virus (FMDV) is an extremely con-
tagious disease of domestic cloven-hoofed animals including
cattle, pigs, sheep, goats, buffalo and more than 70 wildlife species.
The disease is manifested in infected animals by fever, lameness,
and appearance of vesicular lesions of the epithelium of the
mouth, tongue, teats and feet. The virus rapidly spreads via aerosol
and replicates in susceptible animal populations with disease
appearance in 2–14 days following virus exposure and can last
for 7–10 days. Recently, a new species, bovine rhinitis B virus
(BRBV) within the Aphthovirus genus has been described (Hollister
et al., 2008). BRBV causes upper respiratory infections in cattle
characterized by elevated body temperature, increased respiration,
serous nasal discharge, and macroscopic lesions in the lungs.
FMDV contains a positive-sense, single-stranded RNA of 8500
nucleotides that is surrounded by an icosahedral capsid composed
of 60 copies of each of the structural proteins (Grubman and
Baxt, 2004). It codes for a single polyprotein that undergoes
post-translational cleavage resulting in four structural proteins
(VP1, VP2, VP3, and VP4), and ten non-structural proteins (Lpro, 2A,
2B, 2C, 3A, 3B13, 3Cpro, and 3Dpol).
The N-terminus of the polyprotein region of FMDV encodes the
leader protease (Lpro). Lpro is a papain-like proteinase (Kleina and
Grubman, 1992; Roberts and Belsham, 1995; Skern et al., 1998)
that has been shown to be dispensable for virus replication in vitro
but is a virulence determinant at the host-pathogen level. It is
responsible for cleaving itself from the nascent polyprotein as well
as cleaving the eukaryotic initiation factor 4G (eIF4G) resulting in
the shut-off of cap-dependent host cell translation machinery.
Subsequently, a second cleavage of eIF4G occurs during infection
that is mediated by the viral 3Cpro (Belsham et al., 2000). The Lpro
has been shown to relocate to the nucleus of FMDV-infected cells
and to induce degradation of nuclear factor kappa B (NF-κB) with
the consequent inhibition of host innate immune response (de Los
Santos et al., 2006; de Los Santos et al., 2007). Two different forms
of FMDV-Lpro (Lab and Lb) are observed depending on usage of
ﬁrst or second AUG start codon. Translation from the ﬁrst site
results in Lab form of Lpro, which contains 201 amino acids while
the second site produces the predominant, 173 amino acids long
Lb form (Cao et al., 1995; Piccone et al., 1995). Deletion of the Lpro-
coding region in the context of an infectious clone yielded viable
virus progeny only when FMDV polyprotein was translated from
second AUG site suggesting that the Lb is the biologically relevant
form of the Lpro protein (Cao et al., 1995; Piccone et al., 1995).
Genetically engineered serotype A FMDV viruses which lack Lpro
have been shown to be infectious, grow more slowly in cell culture
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(Piccone et al., 1995; Uddowla et al., 2012), and are highly attenuated
in both cattle and swine (Brown et al., 1996; Chinsangaram et al.,
1998; Mason et al., 1997; Uddowla et al., 2012). Marker FMDVs
lacking the Lpro and harboring negative antigenic sites in 3B and 3D
(based on the FMD-LL3B3D virus, Uddowla et al. 2012) were shown
to induce low neutralizing antibody titers in these host species,
which limited their potential use as live attenuated vaccines. Studies
have shown that one of the reasons for the attenuation of the
leaderless (Lpro deleted) virus was its inability to inhibit cellular
translation, speciﬁcally translation of type I alpha/beta interferon
(IFN α/β) that resulted in increased antiviral effects (Chinsangaram
et al., 1999). A recent study has identiﬁed a sequence motif, SAP
(SAF-A/B, Acinus, and PIAS) in FMDV Lpro that when mutated does
not alter self-processing and eIF4G cleavage activities but prevents
inhibition of NF-κB dependent transcription and confers an in vivo
attenuated phenotype (de los Santos et al., 2009).
Although the functions of the BRBV Lpro are poorly understood,
preliminary work suggests that regardless of the sequence diver-
gence (36% amino acid identity), BRBV Lpro is likely to play a role
and perform similar functions as the FMDV counterpart in viral
pathogenesis (Hollister et al., 2008). In this study, we have used
oligonucleotide site directed mutagenesis and reverse genetics to
construct a mutant FMDV containing BRVLpro and a negative
antigenic marker encoded in 3Dpol (A24LBRV3DYR ) using a full-
length cDNA clone of a highly virulent FMDV strain A24WT (Rieder
et al., 2005). This mutant was used to investigate if FMDV Lpro can
be exchanged with the closely related BRBV Lpro both in vitro and
in vivo. We found that the A24LBRV3DYR rescued virus exhibited
growth characteristics in BHK-21 cells similar to A24WT, that LBRV
released itself at the L/VP4 junction, and induced the cleavage of
eukaryotic translation initiation factor eIF4G at early times during
infection. Interestingly, BRBV Lpro in the context of the chimeric
virus was defective at blocking IFN response, with levels compar-
able to that induced by the Lpro deleted mutant FMDV in infected
bovine cells, but this effect was less signiﬁcant in cells of porcine
origin. Furthermore, we found that the A24LBRV3DYR virus was
attenuated in cattle challenged by aerosolization, and showed mild
disease in pigs infected by direct contact with infected pigs.
Results
Derivation and in vitro characterization of A24LBRV3DYR
In order to examine whether the BRBV and FMDV Lpro pro-
teins were functionally interchangeable, we derived a chimeric
pA24LBRV3DYR cDNA clone by exchanging the FMDV Lpro for that of
BRV (Fig. 1A). In addition, two mutations, H27Y and N31R in the
3Dpol were introduced to function as a negative antigenic marker
(as described in our previous studies, (Uddowla et al., 2012). This
clone was linearized, transcribed into RNA, electroporated and the
virus phenotype was studied following passages in BHK-21 cells.
The chimeric virus produced cytopathic effects (CPE) comparable
to A24WT during the early passages. Moreover, full virus sequence
analysis of the A24LBRV3DYR virus recovered from passage 5 showed
the presence of the BRBV Lpro with the engineered marker mutation
in the 3Dpol region without additional changes. For phenotypic
characterization of the chimeric virus, we also examined a pre-
viously described A24LFMDV3DYR virus carrying the FMDV Lpro, and
mutations in 3Dpol that creates a negative antigenic marker
(Uddowla et al., 2012). This particular marker virus has been shown
to be similar to the parental A24WT virus in plaque morphology,
growth kinetics, and pathogenicity in cattle (Uddowla et al., 2012)
(Fig. 1).
First, the plaque morphologies of the mutant and wild-type (WT)
viruses were found to be similar (Fig. 1B). Secondly, a multi-step
growth kinetics performed using a high multiplicity of infection
(MOI¼5) in BHK-21, LFBK, and IBRS-2 cells (Fig. 2A) showed no
signiﬁcant difference in the growth pattern in all three cell lines.
Third, in Western blot analysis, the A24WT and A24LBRV3DYR viruses
exhibited similar kinetics of cleavage of eIF4G. In particular, both
viruses exhibited partial cleavage of eIF4G by 3 h post-infection (hpi)
with complete cleavage by 6 hpi (Fig. 2B). Moreover, the presence of
another non-structural viral protein, 3B, was similarly detected in
both virus-infected cell extracts at 3 hpi. As expected, Western blot
analysis showed only a positive reaction with the parental A24WT
virus, but not with the marker virus using a 3D-speciﬁc monoclonal
antibody (mAb) that recognizes the 3Dpol epitope mutated in the
A24LBRV3DYR chimera (Fig. 2B) (Uddowla et al., 2012). This negative
marker can serve as a useful tool to antigenically distinguish the
chimeric virus from FMDV ﬁeld strains. Consistent with the in vitro
growth patterns, the VP1 capsid protein was detected by Western
blot with both viruses by 6 hpi suggesting that the chimeric virus
was able to undergo viral protein synthesis and processing with
similar kinetics as the A24WT virus (Fig. 2C).
Induction of antiviral activity by A24LBRV3DYR
Previous work has shown that supernatants from cells infected
with leaderless (LL) mutant FMDV induce higher levels of type I
interferon (IFN α/β) activity when compared to supernatants from
WT infected cells (Chinsangaram et al., 1999). Experiments were
Fig. 1. Schematic representation of viral constructs used in this study. The A24LFMDV3DYR virus contains the FMDV Lpro as well as a mutation in 3Dpol that introduces a
negative antigenic site marker (see arrow). In the A24LBRV3DYR virus, the. FMDV Lpro is replaced by the corresponding coding sequence of BRBV. In addition, the mutation in
3Dpol is also present in the chimeric A24LBRV3DYR virus. (B) Plaque size assessment of A24WT, A24LFMDV3DYR, and A24LBRV3DYR viruses in BHK-21 cells. Cells were infected and
after 1 h adsorption, 0.6% gum tragacanth overlay was added, followed 48 h later with crystal violet staining.
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designed to examine A24LBRV3DYR-induced antiviral activity by
using an Mx/CAT ELISA reporter system that has been validated to
measure biologically active type I IFN (Chinsangaram et al., 1999;
Fray et al., 2001). To this end, embryonic bovine and porcine cells
(EBK and EPK, respectively) were infected with A24WT, A24LL,
A24LFMDV3DYR, and A24LBRV3DYR viruses at a MOI of 5, and super-
natants were collected 24 hpi to determine Mx promoter mediated
expression of CAT, using CAT ELISA, as a measure of type I IFN
activity. A mutant of A24WT virus that lacks the Lpro coding region
so-called A24LL, recently characterized (Uddowla et al., 2012) was
used as a positive control since the absence of Lpro has been
implicated in increased antiviral activity in cells (Chinsangaram
et al., 1999). Embryonic kidney cells were used in this experiment
as other FMDV-susceptible established cell lines have been shown
to exhibit impaired type I IFN response (Chinsangaram et al., 2001;
Chinsangaram et al., 1999). Fig. 3 shows that EBK cells infected
with A24 LBRV3DYR produced similar levels of antiviral activity as in
A24LL (virus lacking Lpro) in infected cells. Although the overall
levels of IFN obtained in EPK cells were 10 times lower than those
observed in EBK, A24 LBRV3DYR exhibited a signiﬁcantly reduction
on type I IFN activity when these values were compared to those
of the A24LL virus in EPK cells (Fig. 3). These results suggest that
the chimeric virus induced lower levels of type I IFN production in
cells of bovine and porcine origin. It suppressed antiviral activity
in EPK cells similarly to A24WT while it induced higher IFN activity
in EBK cells when compared to the A24WT virus.
Fig. 2. In vitro characterization of A24LBRV3DYR. (A) Multi-step growth kinetics of A24WT, A24LFMDV3DYR, and A24LBRV3DYR viruses in BHK-21, LFBK and IBRS-2 cell lines
infected at a MOI of 5. (B) Detection of eIF4G intact and cleavage product. Lysates of LFBK cells infected with either A24WT or A24LBRV3DYR viruses were separated on SDS-
PAGE. Western blot analysis was performed using anti-FMDV 3B and 3Dpol as well as anti-eIF4G antibodies. The N-terminus eIF4GI cleavage product (CPN) that is recognized
by the rabbit polyclonal sera used in this experiment is indicated. (C) Capsid processing by A24LBRV3DYR. Lysates of LFBK cells infected with either A24WT or A24LBRV3DYR
viruses were analyzed by Western blot using anti-VP1 antibody.
Fig. 3. Antiviral activity of A24LBRV3DYR virus. Biologically active type I IFN was measured by Mx/CAT ELISA. Bovine (EBK) and porcine (EPK) cells were infected with A24WT,
A243DYR, A24LBRV3DYR and A24LL viruses at a MOI of 5. Supernatants were used to treat MDBK-t2 cells, and CAT binding was measured after 24 h. Results are expressed as
percent (%) of IFN activity normalized to the activity of A24LL virus. Note that the net values for porcine IFN were ten times lower than those observed in bovine cells.
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Virulence and protection study in cattle
In order to investigate the infectivity and virulence of
A24LBRV3DYR in cattle, two steers (#37 and #38) were infected
via a simulated natural (aerosol) inoculation route that has been
successfully utilized previously (Arzt et al., 2010; Pacheco et al.,
2010). During the course of 21 days post-infection (dpi) neither
steer had fever, vesicles, or other clinically detectable abnormal-
ities consistent with FMD (Fig. 4). Despite the absence of clinical
signs, there was evidence of sub-clinical infection in both steers
although the infection dynamics was quite different between the
two animals as judged by measurements of viral RNA in blood,
saliva, and nasal swab samples. In particular, steer #37 had
minimal and intermittent detectable A24LBRV3DYR RNA in secre-
tions (maximum 3 logs RNA CN/ml), and all swab samples were
negative by virus isolation (VI) (data not shown). Similarly, sera
were RNA-negative and VI-negative at all times. At the time of
challenge with virulent FMDV (21 dpi), this animal exhibited a
serum neutralizing antibody titer (SN) of 1.2 log10 (Table 1).
Despite the lack of clinical signs (Fig. 4), substantially more
A24LBRV3DYR RNA and infectious virus were recovered from steer
#38. Viral RNA was detected in nasal and oral swabs from 5–9 dpi
(maximum RNA CN/ml¼5.86, 8 dpi, oral). Steer #38 exhibited
viremia from 4–8 dpi as determined by rRT-PCR and 4–7 dpi by VI
(Fig. 4, data not shown). At the time of challenge with virulent
FMDV (21 dpi), the SN titer of steer #38 was 2.4 log10.
Based on the immune response observed in cattle experimen-
tally infected with A24LBRV3DYR in the absence of clinical FMD
signs, an investigation was pursued to determine whether these
animals could be protected against challenge with the parental A24
WT virus at 21 dpi via intradermolingual route (IDL). For 21 days
post challenge (dpc), neither steer had any fever or vesicles
beyond the inoculation site (Fig. 4, Table 1). Despite the lack of
clinical scores, the challenged steers exhibited limited systemic
dissemination of challenge virus with some variation. Detailed
examination of steer #37 (limited subclinical A24LBRV3DYR infec-
tion; challenge SN¼1.2) indicated that this animal had lingual
vesicles at 1 dpc, exhibited viremia at 2 dpc (23 dpi), and shed
virus in nasal secretions from 1–3 dpc (22–24 dpi). In contrast,
steer #38 (milder subclinical A24LBRV3DYR infection; challenge
SN¼2.4) never developed lingual vesicles; only blanching of
lingual epithelium was apparent at 2 dpc (23 dpi), which was
more evident at 4 dpc (25 dpi) when the affected epithelium
began to slough. Moreover, steer #38 was never viremic subse-
quent to challenge. Both steers were euthanized at 42 dpi/21 dpc
for necropsy and tissue collection. Viral RNA and infectious virus
were recovered from the nasopharyngeal mucosa and draining
lymph nodes of both animals (Arzt et al., manuscript in progress).
Fig. 4. Assessment of A24LBRV3DYR virus virulence in cattle. Animals were inocu-
lated with aerosol containing 1.7106 TCID50 of A24LBRV3DYR virus and were
monitored for clinical disease for 21 days. On day 21 post inoculation (arrows), both
animals were challenged with 104 TCID50 of FMDV A24WT virus. Viral RNA in serum
(■), oral (Δ) and nasal (J) samples are expressed in the left axes; clinical scores
(bars) are expressed in the right axes.
Table 1
Speciﬁc neutralizing antibody response and protection against challenge with
FMDV A24WT strain after aerosol infection with A24LBRV3DYR virus in cattle.
Bovine # Neutralization titer (days post inoculation) Protectionc
0 7 14 21b 28 35 42
37 o0.9a o0.9 o0.9 1.2 3.0 3.0 3.0 Yes
38 o0.9 o0.9 2.4 2.4 3.0 3.3 3.0 Yes
a Virus neutralizing titers of serum antibody responses (log10 of reciprocal of
the last serum dilution to neutralize 100 TCID50 of virus in 50% of the wells).
Sensitivity40.9.
b Day of challenge.
c Cattle were challenged by intradermolingual inoculation of 4 log10 bovine
tongue infectious doses of FMDV A24WT.
Fig. 5. Assessment of A24LBRV3DYR virus virulence in swine. Two donor pigs (#40 and #41) were directly inoculated into the foot bulb with 106 TCID50 of A24LBRV3DYR. After
24 h, two recipient pigs (#42 and #43) were brought into contact with donor animals and housed in the same room for the next eight days. Viral RNA in serum (■), oral (Δ)
and nasal (J) samples are expressed in the left axes; clinical scores (bars) are expressed in the right axesþdenotes fever (4 40 1C).
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Although the distribution of viral RNA was similar in both steers,
infectious virus was recovered from more tissues of steer #37.
Virulence study in pigs
Next, we carried out experiments to investigate the pathogenic
characteristics of A24LBRV3DYR in swine by direct contact infection
that simulates a natural route of exposure. To this end, two donor
pigs (#40 and #41) were inoculated in the heel bulb of the rear
feet with the chimeric virus, brought into contact with two naïve
pigs 24 h later (recipient pigs, #42 and #43), and subsequently all
animals were monitored for 9 dpi/8 dpc for clinical signs of disease
and characterizing virus dynamics. The clinical signs in donor pigs
were moderately attenuated compared to what we have pre-
viously observed in animals infected with the parental A24WT
virus using this route and similar dose (Fig. 5) (Dias et al., 2011;
Pacheco et al., 2012). One donor pig developed fever only on day 2,
but both animals exhibited lesions at non-inoculation sites, with
pig #40 showing lower clinical score. Both animals were viremic
at 1 dpi and ﬁrst developed vesicles at non-inoculation sites at
3–4 dpi. The clinical manifestations of disease in recipient (con-
tact-challenged) pigs were substantially milder (score 1–2) and
delayed compared to the donor directly inoculated pigs (score
6–12). These recipient pigs showed RNA in blood at 2–3 dpc and
vesicles appeared not earlier than 6–8 dpc. Maximum detection of
virus in swab samples occurred at 3–4 dpi for donor pigs and 3 dpc
for both contact-exposed pigs.
Homology modeling of BRBV Lpro
In our previous studies, we showed that the FMD and BRBV
virus Lpro exhibits only 24% invariable amino acids including key
catalytic residues necessary for cleavage at the L/VP4 junction and
of eIF4G (Hollister et al., 2008). We therefore examined the
structural elements that distinguish the BRBV Lpro from the FMDV
counterpart using computer-modeling software. A homology
model was built for BRBV Lpro using 173 amino acids of a type O
FMDV Lbpro for a template (PDB 1QOL, Chain A). As shown in
Fig. 6A, BRBV Lbpro (pink) had high homology with FMDV Lpro
(olive) in terms of its overall three dimensional structure. Despite
overall homology, at the N-terminus, the β1- and β2 strands of
BRBV Lpro are connected by a long disordered loop, ELGFNNTLV-
TADLDGNE (Fig. 6Ai). In contrast, the loop connecting β1- and β2
strands in FMDV Lpro is formed by the tripeptide, LYN for serotype
O, which is LHN in A24WT. Fig. 6 Aii shows critical C-terminal
residues of the two proteases where signiﬁcant differences were
observed. In particular, a stretch of nine amino acids at the
C-terminus of BRBV Lpro forms an uncharged hydrophobic surface
(AEFFKQVYL, Fig. 6 Aii shown in pink). In contrast, the correspond-
ing region of FMDV Lpro consists of charged residues (KAKVQRKLK,
Fig. 6 Aii shown in olive); the abundance of uncharged residues
being 67% and 33% in BRBV and FMDV Lpro, respectively.
In addition, BRBV Lpro is rich in aromatic and non-polar amino
acid side chains at the surface while FMDV Lpro has higher
percentage of charged and polar side chains at the surface.
In spite of these differences and relatively low sequence conserva-
tion between FMDV and BRBV Lpro, the proteases have identical
active sites (Fig. 6 Aiii) and conserved key domain residues
necessary for interaction with eIF4G within the Lpro C-terminal
extension (data not shown, (Foeger et al., 2002)). Fig. 6B shows the
electrostatic surfaces of the two proteases with peptide entry
channels depicted with green arrows. The ﬂoor of the peptide
channel is more positively charged in BRBV Lpro while it is
comparatively neutral in FMDV Lpro. The peptide exit channel of
BRBV protease is narrower in comparison to that of FMDV and
ﬂanked by lysine.
Discussion
Picornavirus-encoded proteinases are known to perform criti-
cal functions in the cleavage of the polyprotein precursor as well as
of cellular proteins targeted in a very regulated fashion. Currently,
the Lpro has been ﬁrmly implicated in pathogenesis of FMDV.
Genetic studies with a leaderless FMD mutant virus have shown
that Lpro is not required for viral replication in cell culture, but
cattle and swine inoculated with the mutant virus exhibited
signiﬁcant attenuation in both species (Brown et al., 1996;
Chinsangaram et al., 1998; Mason et al., 1997; Piccone et al.,
1995; Uddowla et al., 2012). Moreover, earlier studies have shown
that aerosol exposure of cattle with the leaderless virus failed to
spread systemically and resulted in limited replication in the lungs
(Brown et al., 1996). In vitro evidence also suggested that this
attenuation is most likely due to the inability of the leaderless
Fig. 6. Structure of BRBV Lpro homology model. (A) BRBV Lpro (pink) superimposed
onto FMDV Lpro (olive). In order to highlight the key regions showing structural
differences the two protease structures were rotated as indicated in comparison to
the initial description of the FMDV leader protease structure showing left and right
half formed by α-helical and β-sheet structures and active site in top view, see right
panel (Guarne et al., 1998). Inset i shows large long disordered loop, ELGFNNTLV-
TADLDGNE connecting N-terminal β1- and β2 strands of BRBV Lpro in comparison
with small tripeptide, LYN that connects β1- and β2 strands in FMDV Lpro crystal
structure. Inset ii describes the C-terminus of the two proteases. The amino acid
residues of the two proteases are marked with the text in same color (pink for
BRBV Lpro and olive for FMDV Lpro). Inset iii highlights the conservation of
catalytically important amino acid residues (shown as ball and stick) and their
positioning in two proteases. The carbon atoms of the sticks are colored as parent
chain (pink for BRBV and olive for FMDV Lpro), whereas oxygen, nitrogen and sulfer
are colored red, blue and yellow, respectively. (B) Electrostatic surface of the FMDV
and BRBV Lpro. Peptide exit channel is encircled by lysine side chain (K178) in BRBV
Lpro (yellow oval), whereas FMDV Lpro has open peptide exit channel. The peptide
entry channel is shown by green arrow. Blue–white–red colors represent most
positive, neutral and negatively charged surfaces, respectively.
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virus to inhibit IFN production in the host. In fact, a type A
leaderless mutant virus has been shown to be unable to prevent
host translation of IFN α/β mRNAs and secretion of type I IFN
products, thus facilitating the rapid clearance of the virus from the
host (Chinsangaram et al., 1999).
In this study, we sought to generate a chimeric FMD virus to
investigate the extent by which FMDV Lpro can be exchanged with
the closely related BRBV Lpro (Hollister et al., 2008) and assess its
applicability to a live attenuated vaccine. In vitro characterization
of the chimeric A24LBRV3DYR virus provided evidence of partial
functional replacement between FMDV and BRBV Lpro. In particu-
lar, the chimeric virus carrying LBRV displayed similar plaque
phenotype and titer in BHK-21 cells as well as comparable growth
kinetics as the A24WT in hamster, bovine and porcine cell lines
(BHK-21, LFBK and IBRS-2, respectively). Moreover, BRBV Lpro in
the context of a FMDV backbone exhibited the same protease
activity as FMDV Lpro, and was able to cleave eIF4G in a similar
fashion without signiﬁcant detrimental effects on downstream
viral polyprotein processing (Fig. 2). This was evident regardless of
the sequence differences present at the Lpro-VP4 junctions
(A24WT:QKLK↓GAGQSSP; BRBV:VYLR↓GAGSSKP and A24LBRV3DYR:
VYLR↓GAGQSSP). On the other hand, we sought to determine if
BRBV Lpro could block host innate immunity just like the FMDV
counterpart, and based on Mx/CAT ELISA results, we found that
A24LBRV3DYR elicited an antiviral activity in bovine cells that
resembles that found with an attenuated, leader deleted FMDV
mutant (Fig. 3). Speciﬁcally, EBK cells (bovine origin) infected with
A24LBRV3DYR virus secreted similar levels of type I IFN as A24LL-
infected cells using a Mx/CAT ELISA reporter system. The high
levels of type I IFN was in sharp contrast to A24WT and cells
infected with FMDV-containing Lpro and a marker in 3Dpol
(A24LFMDV3DYR) where the IFN response was more limited. The
type I IFN response obtained with the control A24WT virus in
infected bovine cells was consistent with reports showing lower
levels of antiviral activity in cells infected with a type A FMDV
compared to supernatants from LL-mutant infected cells
(Chinsangaram et al., 1999). For reasons we cannot explain, it is
noteworthy that in infected porcine cells the type I IFN values
were lower (by approximately 10 fold) than those observed in
bovine cells. Despite this fact, and in contrast with the observa-
tions in bovine cells, the levels of IFN induced by the chimeric
A24LBRV3DYR virus in EPK cells (porcine origin) were signiﬁcantly
lower to those of the A24LL virus.
Recently, a controlled aerosol inoculation system to deliver
virus in cattle has been described, which mimics a natural route of
exposure (Pacheco et al., 2010). In the current study, a preliminary
experiment using this delivery method in cattle with 106 TCID50 of
chimeric A24LBRV3DYR virus did not show any clinical signs of
disease including vesicular lesions and fever. Examination of two
cattle following virus exposure showed detectable viral RNA in
both nasal and oral swabs within 10 min of inoculation, (as shown
in Fig. 4), indicating that the virus was successfully delivered.
Although sub-clinical in both cases, the dynamics of viral replica-
tion showed differences between the two infected animals. For
instance, one animal had minimal levels of viral RNA in sera and
swab samples with low serum neutralization titer (1.2 at 21 dpi),
while the second animal had more signiﬁcant levels of viral RNA in
blood oral and nasal swaps and higher serum neutralization titer
(2.4 at 21 dpi) prior to challenge. We believe the low virulence of
A24LBRV3DYR chimera is most likely due to the contribution of
BRBV Lpro and not to the mutations engineered in 3D, based on
studies in our laboratory showing that aerosol inoculation with
106 TCID50 of 3D mutant A24LFMDV3DYR virus (carrying the FMDV
Lpro) in cattle, resulted in classical FMD disease (Uddowla et al.,
2012). The immune response induced by the chimeric virus
resulted in protection of both animals against an IDL challenge
with A24WT, following the OIE recommendations protocol for
vaccine trials. Viral RNA was recovered from the lungs and
nasopharynx of cattle following exposure and challenge with
A24LBRV3DYR and A24WT, respectively (data not shown). Therefore,
further studies are being carried out to identify and characterize
the distribution of the virus in tissues collected during necropsy.
Nevertheless, the sites of viral recovery are consistent with the
proﬁles previously observed in cattle that received aerosol inocu-
lation with parental FMDVs and attenuated Lpro mutant viruses
(Arzt et al., 2010; Brown et al., 1996).
To determine if the A24LBRV3DYR virus induces disease in other
susceptible species, a contact transmission experiment in pigs was
also investigated. Inoculation of two donor pigs via the intrader-
mal route (heel bulb) with the chimeric virus resulted in viremia
and signs of clinical disease by days 3 and 4 (Fig. 5). In these
animals, the extent of the clinical disease and dynamics of the viral
infection were moderately attenuated relative to previous studies
using this route of inoculation in pigs and doses of 105–107 TCID50
of parental A24WT-virus (full-blown FMD) (Dias et al., 2011;
Pacheco et al., 2012). For instance, the levels of viral RNA in
secretions were signiﬁcantly lower to those previously observed in
A24WT inoculated animals. In addition, these donor animals did
not exhibit fever during the entire course of the experiment, and
had clinical scores of 6–12 at the end of 9 dpi. The contact
challenged pigs (recipient pigs #42 and #43) exhibited a signiﬁ-
cant delay in the manifestation of clinical symptoms and a milder
form of FMD. The low virulence observed in recipient pigs could be
the result of the additive effect of reduced virus replication and
shedding, resulting from limited transmission of the virus and a
reduced virulence of the chimeric virus expressing the BRBV Lpro
in this species. Together, the data suggest that the FMDV Lpro might
be more effective or better ﬁt to the environment within the
FMDV-targeted cells in the host, than the BRBV Lpro, in agreement
with the fact that FMDV grows faster, produces higher titers, and
spreads more rapidly than BRBV. The observed disease caused by
the chimeric virus in directly inoculated pigs, could be the result of
the high susceptibility of this species combined with the intra-
dermal route of inoculation, which bypasses most of the primary
mechanisms of defense against viral infections. In contrast, swine
in direct contact with these animals, a more natural route of
infection, showed very limited clinical disease. Although evidence
for intertypic and intratypic recombination has been described for
FMDV (Simmonds, 2006), to the best of our knowledge, there are
no reports documenting naturally occurring recombination
between the closely related FMDV and BRBV. Since swine are
not a natural host for BRVB it is unlikely that a recombination
event with FMDV could occur in this species. Additionally, the low
transmission proﬁle and reduced in vivo replication kinetics shown
by the engineered A24LBRV3DYR virus described here suggests less
favorable conditions for natural selection with respect to ﬁeld
FMDV isolates.
In an effort to determine if sequence motifs and/or structural
elements of the BRBV and FMDV Lpro are signiﬁcantly different, we
performed model predictions for LBRV and compared them to the
known features and three-dimensional structure of FMDV Lpro.
Speciﬁcally, the analysis revealed that the active site of BRBV Lpro is
very similar to FMDV Lpro. The catalytic triad in BRV proteinase is
formed by C57, H153 and D158, which correspond to C51, H148
and D163 in FMDV Lpro. Despite this similarity, the N-terminus of
BRBV Lpro has a long disordered loop, which is absent on the FMDV
Lpro. The entire loop is surface-exposed on the BRBV Lpro indicating
its possible role in interaction with other protein(s) or importance
in maintaining the structure/function of the protein during the
infection of the host cell. Future studies will investigate the role of
this loop by mutational analysis in BRBV Lpro and FMDV Lpro.
Interestingly, the C-terminus of BRBV Lpro is highly hydrophobic in
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contrast to highly charged C-terminus of FMDV Lpro. This was also
consistent with our observations that expression of recombinant
BRBV Lpro in Escherichia coli was puriﬁed from insoluble fraction
whereas similar expression system used for FMDV Lpro puriﬁed
this protein from soluble fractions (data not shown). This suggests
possible alterations in BRBV Lpro behavior in the intracellular
membranous web, which is the primary site of replication of
picornaviruses. It is important to note that BRBV Lpro in the context
of the chimeric virus was self-processed and produced eIF4G
cleavage products similar to the FMDV counterpart but we
observed a less efﬁcient IFN blocking activity in cells of bovine
origin when compared with A24WT virus. A recent study by
Pineiro et al. (2012) calls for more investigation into the proteins
that interact with/processed by Leader protease in the cell.
Nogueira Santos et al. (2012) performed FMDV Lpro cleavage of a
number of synthetic peptides and concluded that although Lpro
recognizes its substrate very speciﬁcally, it is the presence not the
order of positively charged (K/R) and small amino acids (G/A) that
is critical to Lpro activity. The observed differences in N and
C-terminus of the BRBV and FMDV Lpro as well as the relatively
high abundance of positive charge at the ﬂoor of peptide binding
cleft of BRBV Lpro suggests that this differences may have impacted
Lpro interaction with host-speciﬁc factor/s.
The pathogenic outcome of FMDV infection in the natural host
is determined by the complex interplay between highly regulated
functions performed by the virus and the host counteracting
response. In the current study, we demonstrated the feasibility
to exchange the FMDV Lpro by the BRBV counterpart, and con-
ﬁrmed previous reports that pathogenic properties of the virus
directly correlates with the ability of Lpro to modulate the innate
immune response. Our observations of partial functional corre-
spondence among related Lpro also suggest that within the
Aphthovirus genus, the Lpro might have evolved to adapt to the
different replication ﬁtnesses of the respective viruses.
Materials and methods
Viruses, cell lines and plasmids
A baby hamster kidney cell line (BHK-21) (ATCC, catalog
number CCL-10) was maintained in Eagle's basal medium (BME)
(Gibco) supplemented with 10% bovine calf serum (BCS) (Hyclone),
10% Tryptose phosphate broth (Sigma), and antibiotic/antimycotic
(Gibco). Monolayers of a bovine kidney cell line (LFBK) (Swaney,
1988) and a porcine kidney cell line (IBRS-2) (de Castro, 1964)
were grown in Eagle's minimal essential medium (EMEM) and
Dulbecco's modiﬁed Eagle's medium (DMEM), respectively, con-
taining 10% fetal calf serum (FCS) (Hyclone) and antibiotic/anti-
mycotic. Embryonic bovine and porcine kidney cell lines (EBK and
EPK, respectively) were kindly provided by Dr. S. Wessman, USDA,
APHIS, Ames, Iowa. EBK and EPK cells were maintained in EMEM
supplemented with 20% FBS, antibiotics and nonessential amino
acids. Madin-Darby bovine kidney (MDBK-t2) cells transfected
with plasmid expressing the human MxA promoter linked to a
chloramphenicol acetyltransferase (CAT) reporter were kindly
provided by B. Charleston (Institute for Animal Health, Pirbright,
United Kingdom). MDBK-t2 cells were maintained in DMEM
supplemented with 10% FBS, antibiotics, glutamine, sodium pyr-
uvate (Invitrogen), and 10 μg/mL blasticidin (Invitrogen). All cells
were grown at 37 1C in a humidiﬁed chamber with 5% CO2
atmosphere. FMDV type A24 Cruzeiro was derived from the
infectious cDNA clone pA24Cru (called here for simplicity A24WT
(Rieder et al., 2005)). A plasmid containing the bovine rhinovirus
type 2 (pBRBV, accession number EU236594) sequence from
poly(C) to poly(A) described previously (Hollister et al., 2008)
was used as a source of bovine rhinovirus genetic material.
In order to derive pA24LBRV, gene fragments were ampliﬁed using
primers P1325 (5′-CCAACTGACACAAACCGTGCAATT) and P1328
(5′-GAAGTCTCTCATAGTCATTCCTGTGGCTCGTGGTAGG) from pA24
Cru template and P1327 (5′-CCTACCACGAGCCACAGGAATGACTACT-
GAGAGACTTC) and P1326 (5′- CTGGATTGGCCGGCCCCTCTCAAGTA-
CACTTGTTTGA) from pBRBV.
The two PCR products were subsequently used as templates to
generate a 1000 bp fragment using P1325 and P1326 that contained
the complete BRBV leader sequence. The product was then inserted
into a LL pA24 using XbaI and FseI restriction sites in order to generate
pA24LBRV. In addition, mutations at codons 27 and 31 of protein 3Dpol
were introduced by PCR utilizing mutagenic oligonucleotides
P1266 (5′-ACCGTTGCGTACGGTGTGTTCCGTCCTGAGTTCGGG) and P1267
(5′-CCCGAACTCAGGACGGAACACACCGTACGCAACGGT). The derivation
of pA243DYR (pA24LFMDV3DYR) was described previously (Uddowla
et al., 2012). The generated plasmids pA24Cru, pA24LFMDV3DYR, and
pA24LBRV3DYR all contain a T7 promoter sequence in front of a
hammerhead ribozyme at the 5′ terminus of the S fragment of the
FMDV genome, and terminates with a poly (A) tract of 15 residues.
Full-length genomic clones were linearized with SwaI and in vitro
transcribed using the T7 Megascript system (Ambion, Austin, TX).
Transcript RNAs were transfected into BHK-21 cells by electropora-
tion as previously described (Rieder et al., 1993). The electroporated
cells were seeded in 6-well plates and incubated for 24–48 h at 37 1C
and 5% CO2. Viruses were serially passaged up to 4 times in BHK-21
and were stored at 70 1C. All viruses were sequenced entirely, and
titers were determined by plaque assays as described below.
Viral growth and plaque assays
For virus growth curves, BHK-21, LFBK and IBRS-2 cells were
infected with A24WT, A24LFMDV3DYR or A24LBRV3DYR at a multi-
plicity of infection (MOI) of 5 plaque forming units (PFU/cell). After
1 h of adsorption at 37 1C, cells were rinsed with MES buffer
(Morpholine Ethane Sulfonic acid 25 mM, 145 mM NaCl, pH 5.5),
then twice with PBS, followed by addition of fresh BME without
serum. At 1, 3, 6, 8, and 24 hpi, viral titers were determined by
inoculating BHIK-21 cells with dilutions of each virus. After 1 h of
adsorption, tragacanth gum overlay (0.6%) was added, and the
cells were further incubated for 48 h at 37 1C. Plates were ﬁxed,
stained with crystal violet (0.3% in Histochoice; Amresco, Solon,
Ohio), and the plaques were counted. The assay was performed in
triplicate, and titers were expressed as log10 of PFU per milliliter
(PFU/mL).
Western blot
LFBK cells were mock-or infected with A24WT or A24LBRV3DYR at
a MOI of 5. At 1, 3, 4 and 6 hpi, infected cells were lysed with RIPA
buffer (1 phosphate buffered solution supplemented with 1%
NaDOC, 0.1% SDS and protease inhibitors) and stored at 70 1C
until further use. Eight microliters of cell lysates were run under
denaturing conditions in 12% Bis-Tris SDS-PAGE gels (Invitrogen)
and transferred onto nitrocellulose membranes using XCell II™
transfer system (Invitrogen). The blots were probed with FMDV-
speciﬁc monoclonal antibodies (mAbs) 6HC4 (1:8) (Robertson
et al., 1984), 40C8 (1:750) and F32-44 (1:200) to detect VP1, 3B
and presence or absence of mutations in the 3D region, respec-
tively. mAbs 40C8 and F32-44 were kindly provided by Dr. Alfonso
Clavijo (TVMDL, Texas A&M, College Station, TX). Cell lysates were
also run in a 3–8% Tris–Acetate SDS-PAGE gel (Invitrogen) and
blotted against rabbit polyclonal eIF4G speciﬁc for the N-terminus
(1:1000, Bethyl Laboratories) to evaluate the cleavage capabilities
of the viruses. Alpha-tubulin (1:1000, Abcam) was used as a
loading control.
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Antiviral activity of A24LBRV3DYR virus
A Mx promoter-chloramphenicol acetyltransferase (Mx/CAT)
reporter gene assay used to determine biologically active type I
IFN was previously described (Fray et al., 2001). EBK and EPK cells
were infected with A24WT, A24LFMDV3DYR, A24LBRV3DYR and A24LL
viruses at a MOI of 5. The A24LL virus has been previously
described and characterized (Uddowla et al., 2012). At 24 h post-
infection, supernatants were collected, and the assay was per-
formed in MDBK-t2 cells as previously described (Perez-Martin
et al., 2012). CAT binding was determined using a commercially
available enzyme linked immunosorbent assay (ELISA) kit (Roche
Applied Sciences) according to manufacturer's protocol.
Virulence and protection study in cattle
All animal experiments were performed in BSL-3 containment
facility under animal experimentation protocols approved by the
facility's Institutional Animal Care and Use Committee. Two 250–
300 kg Holstein steers (ID #37 and #38) were each infected with
1.7106 TCID50 of A24LBRV3DYR via the aerosol route as previously
described (Pacheco et al., 2010). At 21 days post-infection (dpi),
these steers were challenged with 104 TCID50 of the parental
A24WT via intradermolingual injection (O.I.E and O.I.D. 2012).
Discussions of timing of the events in the following passages are
described relative to the initial inoculation of A24LBRV3DYR or
relative to challenge with A24WT [days post challenge (dpc)], as
appropriate. Steers were housed in separate containment rooms
for the entire duration of the procedures described. Clinical
evaluation and sampling (sera, nasal and oral secretions) were
performed on the following schedule: 0–10, 14, 22–31 dpi. Neu-
tralizing antibody titers in cattle sera were determined as
described elsewhere (Golde et al., 2005).
Virulence study in pigs
Two 25–30 kg Yorkshire-cross pigs (ID #40 and #41) were each
inoculated with 2106 TCID50 per pig of A24LBRV3DYR via heel bulb
intraepithelial injection as previously described (Pacheco and
Mason, 2010). At 1 dpi, 2 additional pigs (#42 and #43) were
brought into direct contact with the inoculated pigs, and the four
animals co-habitated with direct contact for the duration of the
study. Clinical evaluation and sampling (sera, nasal and oral
swabs) were performed from 0–9 dpi. Clinical evaluation consisted
of monitoring rectal temperature and lesion scoring as described
(Pacheco and Mason, 2010). Maximum achievable lesion score was
20 for contact-exposed pigs and 16 for inoculated pigs since the
inoculated foot was not used for scoring. Cotton tipped swabs
were used to detect virus from oral and nasal secretions; swabs
were immersed in 2 mL of minimum essential medium with
25 mM HEPES, and were stored at 70 1C from the time of
collection until processing.
FMDV RNA detection
FMDV RNAwas measured in sera and swab samples by rRT-PCR
as previously described (Arzt et al., 2010; Pacheco and Mason,
2010). Virus isolation of samples was performed as previously
described (Pacheco et al., 2010; Swaney, 1988).
Homology model of bovine rhinovirus leader protease
The structure of BRBV Lpro was modeled based on Lpro of FMDV
using PDB ﬁle 1Q0L as template on SWISSMODEL workspace
(Arnold et al., 2006; Peitsch, 1995; Schwede et al., 2003). The
modeled BRBV Lpro was reﬁned using the GROMOS96 43B1 force
ﬁeld in-vacuo (Schmid et al., 2011). The sterochemical quality of
the model was further validated with verify3D (Eisenberg et al.,
1997) and PROCHECK (Laskowski et al., 1993). Electrostatic sur-
faces of the FMDV and BRBV Lpro were generated using adaptive
Poisson–Boltzman algorithm (APBS) (Baker et al., 2001). Figures
were generated with pymol 1.3. rc.
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